Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Nature Medicine

• Publication date

  2000-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/75063PMID 10802716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell mediated immune response to the hepatitis C virus.

  2000cited by this paper
• Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.

  1999cited by this paper
• Class II-independent generation of CD4 memory T cells from effectors.

  1999cited by this paper
• Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.

  1999cited by this paper
• Persistence of memory CD8 T cells in MHC class I-deficient mice.

  1999cited by this paper
• Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection.

  1997cited by this paper
• Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons.

  1997cited by this paper
• Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

  1997cited by this paper
• Serological pattern of hepatitis C virus recurrence after liver transplantation.

  1996cited by this paper
• The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response

  1996cited by this paper
• Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

  1996cited by this paper
• Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.

  1995cited by this paper
• Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.

  1995cited by this paper
• Low Prevalence of Anti-E1 Antibodies Reactive to Recombinant Type 1b E1 Envelope Protein in Type 2, 3, and 4 HCV Sera, but High Prevalence in Subtypes 1a and 1b

  1994cited by this paper
• Viral hepatitis and liver disease

  1984cited by this paper
• Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus

  1970cited by this paper

• Detection of hepatitis B virus surface antigen, IgM and IgG antibodies to hepatitis B virus core antigen in the clinical classification and epidemiological surveillance of HBV infection

  2025cites this paper
• Broadly Neutralizing Antibody Characteristics in Hepatitis C Virus Infection and Implications for Vaccine Design

  2025cites this paper
• NS3 epitope-decorated nanoparticles produced in bacteria trigger potent T cell immunity against hepatitis C virus.

  2025cites this paper
• Coordinated expansion of memory T follicular helper and B cells mediates spontaneous clearance of HCV reinfection

  2024cites this paper
• Biomarkers in Detection of Hepatitis C Virus Infection

  2024cites this paper
• Acute Hepatitis C: Current Status and Future Perspectives

  2024cites this paper
• Early Phase of Specific Cellular Immune Status Associates with HCV Infection Outcomes in Marmosets

  2023cites this paper
• Improved health-related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durable.

  2023cites this paper
• Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host’s Immunity

  2023cites this paper
• Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion

  2023cites this paper
• Acute Hepatitis in an Immunosuppressed Patient: A Dilemma

  2023cites this paper
• Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C

  2023cites this paper
• Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response

  2022cites this paper
• Prevalence of Hepatitis C Virus among the Healthy Blood Donors in the Department of Transfusion Medicine of a Teaching Hospital

  2022cites this paper
• Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort

  2022cites this paper
• CD8+ T-Cell Exhaustion Phenotype in Chronic Hepatitis C Virus Infection Is Associated With Epitope Sequence Variation

  2022cites this paper
• Long-Lasting Virus-Specific T Cell Response with Divergent Features in Self-Resolved and Chronic Hepatitis C Virus Patients 35 Years Postinfection

  2022cites this paper
• Mesenchymal stem cells-based therapy in liver diseases

  2022cites this paper
• Towards a Systems Immunology Approach to Understanding Correlates of Protective Immunity against HCV

  2021cites this paper
• In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure.

  2021cites this paper
• CORRELATION BETWEEN THE ANTIBODY RESPONSE TOWARD SPECIFIC HCV PROTEINS AND HCV VIRAL LOAD

  2021cites this paper
• Expansion of Unique Hepatitis C Virus–Specific Public CD8+ T Cell Clonotypes during Acute Infection and Reinfection

  2021cites this paper
• Chronic Hepatitis C

  2021cites this paper
• In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?

  2021cites this paper
• Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial

  2021cites this paper
• Hepatitis C virus associated hepatocellular carcinoma.

  2021cites this paper
• A SEIRD Model for Analysing the Dynamics of Coronavirus (COVID-19) Pandemic in Nigeria

  2021cites this paper
• A model for analysing the dynamics of the second wave of corona virus (COVID--19) in Nigeria

  2021cites this paper
• A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection

  2021cites this paper
• EASL recommendations on treatment of hepatitis C - Final update of the series.

  2020cites this paper
• T cell immunity to hepatitis C virus: lessons for a prophylactic HCV vaccine.

  2020cites this paper
• Disease-associated antibody phenotypes and probabilistic seroprevalence estimates during the emergence of SARS-CoV-2

  2020cites this paper
• Sensitivity of HCV rapid tests in detecting antibodies in general population.

  2020cites this paper
• Interferon lambda 4 can directly activate human CD19+ B cells and CD8+ T cells

  2020cites this paper
• Fatal Hepatitis C after Chemotherapy in a Patient with Malignant Lymphoma: Possible Reactivation of Seronegative Occult Hepatitis C Virus Infection Due to Chemotherapy

  2020cites this paper
• Hepatitis C

  2020cites this paper
• A Comparative Study on Chemiluminescent Immunoassay with Immunochromatography Test in the Screening Process of Hepatitis B and Hepatitis C

  2020cites this paper
• IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T-cell frequency and increases virus-specific T-cell responses.

  2020cites this paper
• T-Cell Immunity against the Hepatitis C Virus: A Persistent Research Priority in an Era of Highly Effective Therapy.

  2020cites this paper
• Viral Escape Mechanisms in Hepatitis C and the Clinical Consequences of Persistent Infection

  2020cites this paper
• Immune Mechanisms of Viral Clearance and Disease Pathogenesis During Viral Hepatitis

  2020cites this paper
• Impact of Genetic Variants in Inosine Triphosphate Pyrophosphatase and Interferon-λ4 on Natural History, Treatment Response and Ribavirin Pharmacology in Hepatitis C Virus Infection

  2020cites this paper
• Characterizing Hepatitis C Virus–Specific CD4+ T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure

  2020cites this paper
• Infection and Drug Resistance Dovepress

  2019cites this paper
• New treatment of hepatitis C (Direct Acting Antiviral)

  2019cites this paper
• Acute Hepatitis C

  2019cites this paper
• Safety and tolerability of mice to repeated subcutaneous injections of a peptide mix as a potential vaccine against HCV infection

  2019cites this paper
• Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

  2019cites this paper
• Expression of programmed cell death protein 1 and T‐cell immunoglobulin‐ and mucin‐domain‐containing molecule‐3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus

  2019cites this paper
• Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities

  2019cites this paper
• MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection

  2019cites this paper
• Global stability for a mathematical model of hepatitis C: Impact of a possible vaccination with DAAs therapy

  2019cites this paper
• Kobe University Repository : Kernel タイトル Tit le Analysis of Neutralizing Ant ibodies against Hepat it is C Virus in Pat ients Who Were Treated with Pegylated-Interferon plus Ribavirin 著者

  2019cites this paper
• Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.

  2019cites this paper
• Host-Related Predictors of Persistence of Hepatitis C Virus Infection

  2019cites this paper
• Enhanced cytokine responsiveness in natural killer cells from a pilot cohort of uninfected seronegative women exposed to hepatitis C virus contaminated anti-D immunoglobulin

  2019cites this paper
• Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence

  2019cites this paper
• Characterization of functional determinants in the C-terminal part of hepatitis C virus E1 glycoprotein ectodomain

  2019cites this paper
• Antibody and Memory B Cell Responses in Hepatitis E Recovered Individuals, 1–30 Years Post Hepatitis E Virus Infection

  2019cites this paper
• Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions

  2018cites this paper
• Hepatitis C Vaccines, Antibodies, and T Cells

  2018cites this paper
• Rapid decline of anti‐hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV‐infected men who have sex with men

  2018cites this paper
• Enhanced natural killer cell activity is found in exposed uninfected recipients of hepatitis C‐contaminated blood

  2018cites this paper
• Hepatitis C virus infection spontaneous clearance: Has it been underestimated?

  2018cites this paper
• Targeting the Latent Reservoir for HIV‐1

  2018cites this paper
• S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus (HCV) -Infektion“

  2018cites this paper
• Eliminating HIV/HCV co-infection in gay and bisexual men: is it achievable through scaling up treatment?

  2018cites this paper
• T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders

  2018cites this paper
• Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy

  2018cites this paper
• Hepatitis E virus ORF 1 induces proliferative and functional T‐cell responses in patients with ongoing and resolved hepatitis E

  2018cites this paper
• Modelling the elimination of hepatitis C virus infection as a public health threat

  2018cites this paper
• Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success

  2018cites this paper
• Prospective Study of Changes in Anti-HCV Immunoglobulin G Antibody Titers after Treatment with Direct Acting Antiviral Agents

  2018cites this paper
• EASL Recommendations on Treatment of Hepatitis C 2018.

  2018cites this paper
• Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance.

  2018cites this paper
• CD4+ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective.

  2017cites this paper
• Spontaneous Viral Load Decline and Subsequent Clearance of Chronic Hepatitis C Virus in Postpartum Women Correlates With Favorable Interleukin-28B Gene Allele

  2017cites this paper
• Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties

  2017cites this paper
• Dendritic cells activation is associated with sustained virological response to telaprevir treatment of HCV-infected patients.

  2017cites this paper
• Non‐neutralizing epitopes induce robust hepatitis C virus (HCV)‐specific antibody‐dependent CD56+ natural killer cell responses in chronic HCV‐infected patients

  2017cites this paper
• Evaluation of LIAISON® XL system for HBsAg, and anti‐HCV and anti‐HIV/Ag p24

  2017cites this paper
• Mechanism of immune escape from CD8+ T cell response in hepatitis delta virus infection

  2017cites this paper
• Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?

  2017cites this paper
• Current progress in host innate and adaptive immunity against hepatitis C virus infection

  2017cites this paper
• Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C.

  2017cites this paper
• Statistical analysis of sequence populations in virology and immunology (Statistische Analyse von Sequenzpopulationen in der Virologie und Immunologie)

  2017cites this paper
• Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus

  2017cites this paper
• Explorer High Frequency , Sustained T Cell Responses to PARV 4 Suggest Viral Persistence In Vivo

  2017cites this paper
• Innate and Adaptive Immune Responses in Chronic HCV Infection.

  2017cites this paper
• Hepatitis C virus infection

  2017cites this paper
• Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C

  2017cites this paper
• The promise of 4-1BB (CD137) mediated immunomodulation and immunotherapy for viral diseases

  2017cites this paper
• Estimating Loss of Brucella Abortus Antibodies from Age-Specific Serological Data In Elk

  2017cites this paper
• Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance

  2016cites this paper
• Indoleamine‐2,3‐dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B

  2016cites this paper
• Hepatitis C virus: Why an Enigma?

  2016cites this paper
• The Role of Interleukin-10 Gene Polymorphism in Egyptian Patients with Chronic Hepatitis C Virus

  2016cites this paper
• The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence

  2016cites this paper
• Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C.

  2016cites this paper
• Immune responses and immunopathology in acute and chronic viral hepatitis

  2016cites this paper